Hepatitis B y enfermedad celíaca: ¿un motivo de preocupación?

Autores/as

DOI:

https://doi.org/10.22516/25007440.1016

Palabras clave:

Hepatitis B, Enfermedad celiaca, Interferón-alfa, Vacunas

Resumen

Algunas teorías sugieren que el desarrollo de la respuesta inmunitaria para la eliminación de la hepatitis B desencadena el daño del tejido intestinal observado en la enfermedad celíaca en individuos genéticamente predispuestos. Aunque el papel de la infección por el virus de la hepatitis B en el desarrollo de enfermedades autoinmunes se ha discutido ampliamente en la literatura, sigue siendo un tema controvertido. Nuestro objetivo es revisar si existe una asociación entre la hepatitis B y la enfermedad celíaca y las particularidades de la vacunación contra la hepatitis B en pacientes celíacos.

Descargas

Los datos de descargas todavía no están disponibles.

Biografía del autor/a

Janaina Luz Narciso-Schiavon, Universidade Federal de Santa Catarina

Doctora en gastroenterología, Universidad Federal de Santa Catarina de Sao Paulo. Profesora de Gastroenterología del Departamento de Clínica Médica, Universidad Federal de Santa Catarina. Santa Catarina SC, Brasil.

Leonardo de Lucca Schiavon, Universidad Federal de Santa Catarina

División de Gastroenterología, Unidad del Sistema Digestivo, Hospital Universitario, Universidad Federal de Santa Catarina. Santa Catarina SC, Brasil.

Referencias bibliográficas

Freeman HJ. Celiac disease: a disorder emerging from antiquity, its evolving classification and risk, and potential new treatment paradigms. Gut and liver. 2015;9(1):28-37. https://doi.org/10.5009/gnl14288

Green PH, Jabri B. Coeliac disease. Lancet. 2003;362(9381):383-91. https://doi.org/10.1016/S0140-6736(03)14027-5

Hadjivassiliou M, Sanders DS, Grunewald RA, Woodroofe N, Boscolo S, Aeschlimann D. Gluten sensitivity: from gut to brain. Lancet Neurol. 2010;9(3):318-30. https://doi.org/10.1016/S1474-4422(09)70290-X

Yoosuf S, Singh P, Khaitan A, Strand T, Ahuja V, Makharia GK. Prevalence of celiac disease in patients with liver diseases: a systematic review and meta-analyses. Am J Gastroenterol. 2023;118(5):820-32. https://doi.org/10.14309/ajg.0000000000002123

Kumar V, Jarzabek-Chorzelska M, Sulej J, Karnewska K, Farrell T, Jablonska S. Celiac disease and immunoglobulin a deficiency: how effective are the serological methods of diagnosis? Clin Diagn Lab Immunol. 2002;9(6):1295-300. https://doi.org/10.1128/CDLI.9.6.1295-1300.2002

Leffler DA, Schuppan D. Update on serologic testing in celiac disease. Am J Gastroenterol. 2010;105(12):2520-4. https://doi.org/10.1038/ajg.2010.276

Marsh MN. Gluten, major histocompatibility complex, and the small intestine. Gastroenterology. 1992;102(1):330-54. https://doi.org/10.1016/0016-5085(92)91819-P

Narciso-Schiavon JL, Schiavon LL. To screen or not to screen? Celiac antibodies in liver diseases. World J Gastroenterol. 2017;23(5):776-91. https://doi.org/10.3748/wjg.v23.i5.776

Narciso-Schiavon JL, Schiavon LL. Celiac disease screening in patients with cryptogenic cirrhosis. World J Gastroenterol. 2023;29(2):410-2. https://doi.org/10.3748/wjg.v29.i2.410

World Health Organization (WHO). Hepatitis B vaccines: WHO position paper; 2017. Wkly Epidemiol Rec. 2017;92(27):369-92.

Leonardi S, La Rosa M. Are hepatitis B virus and celiac disease linked? Hepat Mon. 2010;10(3):173-5.

Sima H, Hekmatdoost A, Ghaziani T, Alavian SM, Mashayekh A, Zali MR. The prevalence of celiac autoantibodies in hepatitis patients. Iran J Allergy Asthma Immunol. 2010;9(3):157-62.

Nau AL, Fayad L, Lazzarotto C, Shiozawa MB, Dantas-Corrêa EB, Schiavon LL, et al. Prevalence and clinical features of celiac disease in patients with hepatitis B virus infection in Southern Brazil. Rev Soc Bras Med Trop. 2013;46(4):397-402. https://doi.org/10.1590/0037-8682-0093-2013

Sood A, Khurana MS, Mahajan R, Midha V, Puri S, Kaur A, et al. Prevalence and clinical significance of IgA anti-tissue transglutaminase antibodies in patients with chronic liver disease. J Gastroenterol Hepatol. 2017;32(2):446-50. https://doi.org/10.1111/jgh.13474

Tursi A. Celiac disease and viral B hepatitis: lessons for clinical practice. Hepat Mon. 2010;10(4):311-2.

Stroffolini T, Almasio PL, Sagnelli E, Mele A, Gaeta GB. Evolving clinical landscape of chronic hepatitis B: A multicenter Italian study. J Med Virol. 2009;81(12):1999-2006. https://doi.org/10.1002/jmv.21643

Gasbarrini G, Miele L, Malandrino N, Grieco A, Addolorato G, Gasbarrini A, Cammarota G, Bonvicini F. Celiac disease in the 21st century: issues of under- and over-diagnosis. Int J Immunopathol Pharmacol. 2009;22(1):1-7. https://doi.org/10.1177/039463200902200101

Corrêa WK. Considerações sobre a formação territorial e econômica de Santa Catarina. Geosul. 1999;14(27):25-44.

Soto Iglesias S, Vazquez Rodriguez S, Ulla Rocha JL, Baltar Arias R, Diaz Saa W, Barrio Antoranz J, et al. [Onset of celiac disease after acute hepatitis B infection]. Gastroenterol Hepatol. 2010;33(1):17-20. https://doi.org/10.1016/j.gastrohep.2009.06.005

Bardella MT, Fraquelli M, Quatrini M, Molteni N, Bianchi P, Conte D. Prevalence of hypertransaminasemia in adult celiac patients and effect of gluten-free diet. Hepatology. 1995;22(3):833-6.

Novacek G, Miehsler W, Wrba F, Ferenci P, Penner E, Vogelsang H. Prevalence and clinical importance of hypertransaminasaemia in coeliac disease. Eur. J. Gastroenterol. Hepatol. 1999;11(3):283-8. https://doi.org/10.1097/00042737-199903000-00012

Moghaddam MA, Rostami Nejad M, Shalmani HM, Rostami K, Nazemalhosseini Mojarad E, Aldulaimi D, et al. The effects of gluten-free diet on hypertransaminasemia in patients with celiac disease. Int J Prev Med. 2013;4(6):700-4.

Tanwar A, Gupta GK, Chauhan V, Sharma D, Jain MK, Bhardwaj H, et al. Celiac Disease and Portal Hypertension: A Causal Association or Just a Coincidence? J Clin Exp Hepatol. 2020;10(4):290-5. https://doi.org/10.1016/j.jceh.2019.11.005

Ye J, Chen J. Interferon and Hepatitis B: Current and Future Perspectives. Front Immunol. 2021;12:733364. https://doi.org/10.3389/fimmu.2021.733364

Bardella MT, Marino R, Meroni PL. Celiac disease during interferon treatment. Ann Intern Med. 1999;131(2):157-8. https://doi.org/10.7326/0003-4819-131-2-199907200-00024

Cammarota G, Cuoco L, Cianci R, Pandolfi F, Gasbarrini G. Onset of celiac disease during treatment with Interferon for chronic hepatitis C. Lancet. 2000;356(9240):1494-5. https://doi.org/10.1016/S0140-6736(00)02880-4

Adinolfi LE, Durante Mangoni E, Andreana A. Interferon and Ribavirin treatment for chronic hepatitis C may activate celiac disease. Am J Gastroenterology. 2001;96(2):607-8. https://doi.org/10.1111/j.1572-0241.2001.03574.x

Monteleone G, Pender SL, Alstead E, Hauer AC, Lionetti P, McKenzie C, et al. Role of interferon α in promoting T helper cell type 1 responses in the small intestine in celiac disease. Gut. 2001;48(3):425-9. https://doi.org/10.1136/gut.48.3.425

Narvaes I, Belen P, Mar Alcalde M, Jimenez C, Soria A. Chronic viral hepatitis, Interferon, diabetes mellitus, and celiac disease. Am J Gastroenterol. 2003;98(10):2336-7. https://doi.org/10.1111/j.1572-0241.2003.07652.x

Shaw Jr FE, Guess HA, Roets JM, Mohr FE, Coleman PJ, Mandel EJ, et al. Effect of anatomic injection site, age and smoking on the immune response to hepatitis B vaccination. Vaccine. 1989;7(5):425-30. https://doi.org/10.1016/0264-410X(89)90157-6

Treadwell TL, Keeffe EB, Lake J, Read A, Friedman LS, Goldman IS, et al. Immunogenicity of two recombinant hepatitis B vaccines in older individuals. Am J Med. 1993;95(6):584-8. https://doi.org/10.1016/0002-9343(93)90353-Q

Romano L, Zanetti AR. Hepatitis B Vaccination: A Historical Overview with a Focus on the Italian Achievements. Viruses. 2022;14(7):1515. https://doi.org/10.3390/v14071515

Leonardi S, Spina M, Spicuzza L, Rotolo N, La Rosa M. Hepatitis B vaccination failure in celiac disease: is there a need to reassess current immunization strategies? Vaccine. 2009;27(43):6030-3. https://doi.org/10.1016/j.vaccine.2009.07.099

Nemes E, Lefler E, Szegedi L, Kapitany A, Kovacs JB, Balogh M, et al. Gluten intake interferes with the humoral immune response to recombinant hepatitis B vaccine in patients with celiac disease. Pediatrics. 2008;121(6):e1570-6. https://doi.org/10.1542/peds.2007-2446

Ahishali E, Boztas G, Akyuz F, Ibrisim D, Poturoglu S, Pinarbasi B, et al. Response to hepatitis B vaccination in patients with celiac disease. Dig Dis Sci. 2008;53(8):2156-9. https://doi.org/10.1007/s10620-007-0128-3

Park SD, Markowitz J, Pettei M, Weinstein T, Sison CP, Swiss SR, et al. Failure to respond to hepatitis B vaccine in children with celiac disease. J Pediatr Gastroenterol Nutr. 2007;44(4):431-5. https://doi.org/10.1097/MPG.0b013e3180320654

Belloni C, Avanzini MA, De Silvestri A, Martinetti M, Pasi A, Coslovich E, et al. No evidence of autoimmunity in 6-year-old children immunized at birth with recombinant hepatitis B vaccine. Pediatrics. 2002;110(1 Pt 1):e4. https://doi.org/10.1542/peds.110.1.e4

Desombere I, Willems A, Leroux-Roels G. Response to hepatitis B vaccine: multiple HLA genes are involved. Tissue Antigens. 1998;51(6):593-604. https://doi.org/10.1111/j.1399-0039.1998.tb03001.x

Alper CA, Kruskall MS, Marcus-Bagley D, Craven DE, Katz AJ, Brink SJ, et al. Genetic prediction of nonresponse to hepatitis B vaccine. N Engl J Med. 1989;321(11):708-12. https://doi.org/10.1056/NEJM198909143211103

Trovato CM, Montuori M, Sansone A, Morelli A, Russo G, Pietropaoli N, et al. Association between Elevated TGA-IgA Titers and Older Age at Diagnosis with Absence of HBV Seroconversion in Celiac Children. Vaccines (Basel). 2021;9(2):101. https://doi.org/10.3390/vaccines9020101

Ertem D, Gonen I, Tanidir C, Ugras M, Yildiz A, Pehlivanoglu E, et al. The response to hepatitis B vaccine: does it differ in celiac disease? Eur J Gastroenterol Hepatol. 2010;22(7):787-93. https://doi.org/10.1097/MEG.0b013e32832e9d41

Rousseff T, Claeys T, Vande Vijver E, Moes N, Vande Velde S, Schelstraete P, et al. Hepatitis B virus vaccination and revaccination response in children diagnosed with coeliac disease: a multicentre prospective study. Acta Gastroenterol Belg. 2019;82(1):27-30.

Leonardi S, Praticò AD, Lionetti E, Spina M, Vitaliti G, Rosa ML. Intramuscular vs intradermal route for hepatitis B booster vaccine in celiac children. World J Gastroenterol. 2012;18(40):5729-33. https://doi.org/10.3748/wjg.v18.i40.5729

Sangfelt P, Uhnoo I, Reichard O, Weiland O. A low-dose intradermal hepatitis B vaccine programme in health-care workers and students is highly effective and cost saving: a retrospective follow-up survey in the clinical setting. Scand J Gastroenterol. 2008;43(4):465-72. https://doi.org/10.1080/00365520701733806

Vitaliti G, Praticò AD, Cimino C, Di Dio G, Lionetti E, La Rosa M, Leonardi S. Hepatitis B vaccine in celiac disease: yesterday, today and tomorrow. World J Gastroenterol 2013;19(6):838-45. https://doi.org/10.3748/wjg.v19.i6.838

Zingone F, Morisco F, Zanetti A, Romanò L, Portella G, Capone P, et al. Long-term antibody persistence and immune memory to hepatitis B virus in adult celiac patients vaccinated as adolescents. Vaccine. 2011;29(5):1005-8. https://doi.org/10.1016/j.vaccine.2010.11.060

Figura 1. Algoritmo diagnóstico de la enfermedad celíaca.

Descargas

Publicado

2023-12-19

Cómo citar

Narciso-Schiavon, J. L., & Schiavon, L. de L. (2023). Hepatitis B y enfermedad celíaca: ¿un motivo de preocupación?. Revista Colombiana De Gastroenterología, 38(4), 479–485. https://doi.org/10.22516/25007440.1016

Número

Sección

Revisión de tema

Métricas

Crossref Cited-by logo
Estadísticas de artículo
Vistas de resúmenes
Vistas de PDF
Descargas de PDF
Vistas de HTML
Otras vistas
QR Code

Algunos artículos similares: